NEW YORK (GenomeWeb News) – Fitch Ratings today affirmed Bio-Rad's ratings, noting the firm's stability and strong cash position but warning against continued macroeconomic headwinds.

Included in the ratings is a BBB- for Issuer Default Rating; BBB- for senior secured bank facility; BBB- for senior unsecured notes; and BB+ for senior subordinated notes.

The rating outlook for the Hercules, Calif.-based company is stable, Fitch said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.